MIAMI, FLORIDA. October 25, 2018 — ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, announced that Vitthal Gouri, Associate Vice President, Clinical Solutions at ArisGlobal, will present “Artificial Intelligence in Clinical Trials Automation” at Partnerships in Clinical Trials Europe, scheduled for November 27-29, 2018 in Barcelona, Spain.
The half-hour session, scheduled for November 29th, 10:00 a.m. will explore the number of different ways that today’s cutting-edge technologies can be leveraged to dramatically improve clinical trials through automation.
“As the cost of drug development and time to market continues to increase, it’s time to look beyond traditional technical solutions and embrace how artificial intelligence and machine learning can significantly improve quality, resource efficiency, and overall time in bringing products and devices to market,” says Vitthal. “Recent research suggests that these advanced technologies can significantly reduce the time, and cut the cost by more than half.”
Vitthal leads the LifeSphere® Clinical business unit, ArisGlobal’s multi-tenant cloud-based eClinical platform for clinical operations and clinical data management that leverages industry standard practices and cognitive computing to efficiently automate core business processes.
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.